Djaballah; Hakim
Patent Applications and Registrations
Patent applications and USPTO patent grants for Djaballah; Hakim.The latest application filed is for "cdc7 kinase inhibitors and uses thereof".
- Djaballah; Hakim - Scarsdale NY
- Djaballah, Hakim - San Diego CA
| Patent | Date |
|---|---|
| Cdc7 Kinase Inhibitors And Uses Thereof App 20210283099 - Frattini; Mark G. ; et al. | 2021-09-16 |
| Cdc7 kinase inhibitors and uses thereof Grant 11,045,446 - Frattini , et al. June 29, 2 | 2021-06-29 |
| Cdc7 Kinase Inhibitors And Uses Thereof App 20190314329 - Frattini; Mark G. ; et al. | 2019-10-17 |
| CDC7 kinase inhibitors and uses thereof Grant 10,123,992 - Frattini , et al. November 13, 2 | 2018-11-13 |
| Cdc7 Kinase Inhibitors And Uses Thereof App 20180125815 - Frattini; Mark G. ; et al. | 2018-05-10 |
| CDC7 kinase inhibitors and uses thereof Grant 9,782,386 - Frattini , et al. October 10, 2 | 2017-10-10 |
| Cdc7 Kinase Inhibitors And Uses Thereof App 20170119731 - Frattini; Mark G. ; et al. | 2017-05-04 |
| Substituted pyridazines as EGFR and/or KRAS inhibitors Grant 9,562,019 - Djaballah , et al. February 7, 2 | 2017-02-07 |
| CDC7 kinase inhibitors and uses thereof Grant 9,492,427 - Frattini , et al. November 15, 2 | 2016-11-15 |
| Cdc7 Kinase Inhibitors And Uses Thereof App 20160058733 - Frattini; Mark G. ; et al. | 2016-03-03 |
| CDC7 kinase inhibitors and uses thereof Grant 9,180,105 - Frattini , et al. November 10, 2 | 2015-11-10 |
| Indole Compounds And Their Use As Antimicrobials App 20150291565 - Djaballah; Hakim ; et al. | 2015-10-15 |
| Coumarin-based Compounds For The Treatment Of Alzheimer's Disease And Cancer App 20150133493 - Zhu; Lei ; et al. | 2015-05-14 |
| Cephalotaxus esters, methods of synthesis, and uses thereof Grant 9,006,231 - Gin , et al. April 14, 2 | 2015-04-14 |
| Cephalotaxus Esters, Methods Of Synthesis, And Uses Thereof App 20140171416 - Gin; David Y. ; et al. | 2014-06-19 |
| Benzofuran-4,5-diones as selective peptide deformylase inhibitors Grant 8,614,237 - Djaballah , et al. December 24, 2 | 2013-12-24 |
| Cephalotaxus esters, methods of synthesis, and uses thereof Grant 8,466,142 - Gin , et al. June 18, 2 | 2013-06-18 |
| Pyridazinones And Furan-containing Compounds App 20130131062 - Djaballah; Hakim ; et al. | 2013-05-23 |
| Compounds For The Treatment Of Ocular Cancer App 20130035321 - Djaballah; Hakim ; et al. | 2013-02-07 |
| Cdc7 Kinase Inhibitors And Uses Thereof App 20130035301 - Frattini; Mark G. ; et al. | 2013-02-07 |
| Benzofuran-4,5-diones As Selective Peptide Deformylase Inhibitors App 20120071523 - Djaballah; Hakim ; et al. | 2012-03-22 |
| Cardenolides For The Treatment Of Ocular Cancer App 20110311651 - Djaballah; Hakim ; et al. | 2011-12-22 |
| Coumarin-based Compounds For The Treatment Of Alzheimer's Disease And Cancer App 20110306605 - Zhu; Lei ; et al. | 2011-12-15 |
| Cephalotaxus Esters, Methods Of Synthesis, And Uses Thereof App 20110071097 - Gin; David ; et al. | 2011-03-24 |
| Pyridazinones And Furan-containing Compounds App 20100210649 - Djaballah; Hakim ; et al. | 2010-08-19 |
| Methods of screening for ligands of target molecules App 20030059811 - Djaballah, Hakim ; et al. | 2003-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 